SEC Form 4 · accession 0001628280-26-040215
PRECISION BIOSCIENCES INC · DTIL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Alexander Kelly
Officer — Chief Financial Officer
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001357874
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 1, 2026 | A | 193,688 | A | — | — | Common Stock | 193,688 | 193,688 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
- F2Award vests in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.